Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ursodeoxycholic acid (2 trials)
Ursodoxicoltaurine (2 trials)
Cholestasis (Phase 3)
Fibrosis (Phase 3)
Liver Cirrhosis (Phase 3)
Liver Cirrhosis, Biliary (Phase 3)
Liver Diseases (Phase 3)
Trials (2 total)
Trial APIs (2 total)